Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
出版年份 2014 全文链接
标题
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
作者
关键词
-
出版物
MOLECULES
Volume 19, Issue 9, Pages 13848-13877
出版商
MDPI AG
发表日期
2014-09-08
DOI
10.3390/molecules190913848
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
- (2015) De-Shen Wang et al. Oncotarget
- Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
- (2014) Yi-Jun Wang et al. BIOCHEMICAL PHARMACOLOGY
- Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
- (2014) Kamlesh Sodani et al. BIOCHEMICAL PHARMACOLOGY
- AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
- (2014) Hui Zhang et al. CANCER LETTERS
- Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance
- (2014) Hui Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
- (2014) RISHIL J. KATHAWALA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10-Mediated Paclitaxel Resistance: A Preclinical Study
- (2014) R. J. Kathawala et al. MOLECULAR CANCER THERAPEUTICS
- Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
- (2014) YUE-LI SUN et al. ONCOLOGY REPORTS
- PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
- (2014) Nagaraju Anreddy et al. Acta Pharmaceutica Sinica B
- PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
- (2013) Atish Patel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience
- (2013) V. Brazzelli et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
- (2013) Yuankai Shi et al. LANCET ONCOLOGY
- Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
- (2013) Rishil J. Kathawala et al. Chinese Journal of Cancer
- Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
- (2012) Dariusz Pytel et al. Anti-Cancer Agents in Medicinal Chemistry
- Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
- (2012) Amit K. Tiwari et al. CANCER LETTERS
- Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib
- (2012) Mukul Minocha et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
- (2012) R. Sen et al. MOLECULAR CANCER THERAPEUTICS
- Reversing multidrug resistance by tyrosine kinase inhibitors
- (2012) Miao He et al. Chinese Journal of Cancer
- Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib
- (2011) Yoshihiko Shibayama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group
- (2011) Uwe Pelzer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice
- (2011) E. A. Hopper-Borge et al. CANCER RESEARCH
- Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
- (2011) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
- (2011) Amit K. Tiwari et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- ABC transporters, mechanisms and biology: an overview
- (2011) I. Barry Holland Essays in Biochemistry
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
- (2011) Anna Brózik et al. Expert Opinion on Drug Metabolism & Toxicology
- Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays
- (2011) Petra Krumpochova et al. FASEB JOURNAL
- Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells
- (2011) Wei-Chien Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reversal of Multidrug Resistance by Morning Glory Resin Glycosides in Human Breast Cancer Cells
- (2011) Gabriela Figueroa-González et al. JOURNAL OF NATURAL PRODUCTS
- Synthesis and Characterization of a BODIPY Conjugate of the BCR-ABL Kinase Inhibitor Tasigna (Nilotinib): Evidence for Transport of Tasigna and Its Fluorescent Derivative by ABC Drug Transporters
- (2011) Suneet Shukla et al. MOLECULAR PHARMACEUTICS
- The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Identification ofABCG2Dysfunction as a Major Factor Contributing to Gout
- (2011) H. Matsuo et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro
- (2011) Stefan Balabanov et al. PLoS One
- Ontogeny of sulfonylurea-binding regulatory subunits of KATP channels in the pregnant rat myometrium
- (2011) N Lovasz et al. REPRODUCTION
- Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells
- (2011) Xing-Xiang Peng et al. Chinese Journal of Cancer
- Multidrug resistance associated proteins in multidrug resistance
- (2011) Kamlesh Sodani et al. Chinese Journal of Cancer
- L-asparaginase treatment in acute lymphoblastic leukemia
- (2010) Rob Pieters et al. CANCER
- Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases
- (2010) Mario Pérez-Sayáns et al. CANCER LETTERS
- Interaction of Tyrosine Kinase Inhibitors with the MDR-Related ABC Transporter Proteins
- (2010) Xiao-Kun Wang et al. CURRENT DRUG METABOLISM
- The ATPase activities of sulfonylurea receptor 2A and sulfonylurea receptor 2B are influenced by the C-terminal 42 amino acids
- (2010) Heidi de Wet et al. FEBS Journal
- First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab
- (2010) Carmen Schweighofer OncoTargets and Therapy
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
- (2010) Chung-Pu Wu et al. Current Molecular Pharmacology
- Nilotinib (AMN107, Tasigna ® ) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
- (2009) Amit K. Tiwari et al. BIOCHEMICAL PHARMACOLOGY
- Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
- (2009) Ye-Hong Kuang et al. BIOCHEMICAL PHARMACOLOGY
- Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties
- (2009) C Hegedűs et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2
- (2009) Chun-ling Dai et al. CANCER LETTERS
- Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters
- (2009) S. Hu et al. CLINICAL CANCER RESEARCH
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
- (2009) Y. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Ross A Soo et al. LANCET ONCOLOGY
- Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
- (2009) D K Hiwase et al. LEUKEMIA
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
- (2009) Pasi A. Jänne et al. NATURE REVIEWS DRUG DISCOVERY
- Imatinib is a substrate for various multidrug resistance proteins
- (2009) K. Czyzewski et al. NEOPLASMA
- Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
- (2009) Tong Shen et al. PLoS One
- Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
- (2009) Fu-Shing Liu Taiwanese Journal of Obstetrics & Gynecology
- Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia
- (2008) A. Giannoudis et al. BLOOD
- Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
- (2008) C Lemos et al. BRITISH JOURNAL OF CANCER
- Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
- (2008) F.-X. Mahon et al. CANCER RESEARCH
- Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
- (2008) C.-l. Dai et al. CANCER RESEARCH
- Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
- (2008) D. K. Hiwase et al. CLINICAL CANCER RESEARCH
- Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2
- (2008) S. Shukla et al. DRUG METABOLISM AND DISPOSITION
- Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development ofin vitrohigh-speed screening systems
- (2008) Ai Tamura et al. Expert Opinion on Drug Metabolism & Toxicology
- Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
- (2008) Suneet Shukla et al. Expert Opinion on Drug Metabolism & Toxicology
- Imatinib resistance in multidrug-resistant K562 human leukemic cells
- (2008) Yanina Assef et al. LEUKEMIA RESEARCH
- Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
- (2008) S. Marchetti et al. MOLECULAR CANCER THERAPEUTICS
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started